Vanessa J. van Ham

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Nadine van Montfoort, Linda Borst, Michael Korrer et al. · Cell · 2018 · 317 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +10

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

Marij J.P. Welters, Tetje C. van der Sluis, Hélène van Meir et al. · Science Translational Medicine · 2016 · 207 citations

Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer

Marij J.P. Welters, Wenbo Ma, Saskia J. Santegoets et al. · Clinical Cancer Research · 2017 · 162 citations · Full text

The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival

Saskia J. Santegoets, Vanessa J. van Ham, Ilina Ehsan et al. · Clinical Cancer Research · 2018 · 56 citations

High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status

Kim E. Kortekaas, Saskia J. Santegoets, Ziena Abdulrahman et al. · Journal for ImmunoTherapy of Cancer · 2019 · 43 citations · Full text